Showing results (71-80 of 146) with videos related to
Sort By:
Pageof 15
Plos One|July 26, 2012
Chronic kidney disease-induced cardiac fibrosis is ameliorated by reducing circulating levels of a non-dialysable uremic toxin, indoxyl sulfateSuree Lekawanvijit, Andrew R Kompa, Minako Manabe, et al.Physiological Reports|April 22, 2015
Contribution of microRNA to pathological fibrosis in cardio-renal syndrome: impact of uremic toxinsIndrajeetsinh Rana, Andrew R Kompa, Joanna Skommer, et al.Journal of the American Society of Nephrology : JASN|February 13, 2009
PKC-beta1 mediates glucose-induced Akt activation and TGF-beta1 upregulation in mesangial cellsDongcheng Wu, Fangfang Peng, Baifang Zhang, et al.International Journal of Cardiology|March 17, 2018
Angiotensin receptor neprilysin inhibition provides superior cardioprotection compared to angiotensin converting enzyme inhibition after experimental myocardial infarctionAndrew R Kompa, Jiayu Lu, Thomas J Weller, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 11, 2003
Does vascular endothelial growth factor (VEGF) play a role in the pathogenesis of minimal change disease?Geoffrey Boner, Alison J Cox, Darren J Kelly, et al.Life Sciences|December 13, 2021
NP202 treatment improves left ventricular systolic function and attenuates pathological remodelling following chronic myocardial infarctionAndrew R Kompa, Fay L Khong, Yuan Zhang, et al.Plos One|August 11, 2011
3',4'-Dihydroxyflavonol antioxidant attenuates diastolic dysfunction and cardiac remodeling in streptozotocin-induced diabetic m(Ren2)27 ratsFay Lin Khong, Yuan Zhang, Amanda J Edgley, et al.Heart, Lung & Circulation|September 19, 2012
Early and delayed tranilast treatment reduces pathological fibrosis following myocardial infarctionFiona See, Masataka Watanabe, Andrew R Kompa, et al.Diabetes Care|November 30, 2006
Transforming growth factor-beta in human diabetic nephropathy: effects of ACE inhibitionRobyn G Langham, Darren J Kelly, Renae M Gow, et al.Nephrology (Carlton, Vic.)|May 18, 2011
Protein kinase C β inhibition ameliorates experimental mesangial proliferative glomerulonephritisHirobumi Tokuyama, Sandra Kim, Yuan Zhang, et al.Pageof 15